Skip to content

What’s New in Caring for People Living with HIV Infection? An Update for the Pharmacist

This on-demand module will provide pharmacists with updated information on treatment options for people living with HIV. Content includes introductions to new treatment types, regimens, and overview clinical trial data. Following this activity, participants should be able to assist with infection management and incorporate the information into patient counseling.

Learning Objectives

Upon completion of this activity, the participant will be able to:

  • Discuss selection of initial antiretroviral therapy for an individual patient, including dosing, adverse effects, food requirements, and patient counseling points
  • Identify the role of recently approved agents in the treatment of HIV infection, including long acting cabotegravir plus rilpivirine
  • Plan how to incorporate counseling for people living with HIV infection into a variety of pharmacy practice settings


Linda Spooner, PharmD, BCPS, FASHP, FCCP | Professor of Pharmacy Practice
Massachusetts School of Pharmacy and Health Science

Registration Fee: Free for MCPHS alumni and full-time employees; $12.00 for all other professionals. Registration is required to earn ACPE credit.


Release Date: March 10, 2022
Expiration Date: March 24, 2023
Universal Activity Number:  0026-0000-22-103-H02-P | Knowledge
Contact Hour: 1 (0.1 CEU)
Topic Designator: AIDS Therapy


ACPE logo

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. MCPHS designates this educational activity for a total of 1.0 contact hours (0.1 CEUs).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.


All participants will have the opportunity to review the educational session and speakers, and to identify future educational needs.

Statement of Disclosure

Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.

Linda Spooner has attended a one day advisory board meeting for TheraTechnologies. Conflicts have been mitigated through a peer review process per MCPHS Policy.

Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.

No funding from industry provided for this event. No exhibitors will be present.

Off-label/investigational uses of a lenacapavir will be discussed. This agent is on a clinical hold at this time (1/2022).